ceftazidime

This page shows the latest ceftazidime news and features for those working in and with pharma, biotech and healthcare.

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

Originally developed by Actavis (which was acquired by Allergan in a $25bn deal in 2014), Avycaz combines established cephalosporin antibiotic ceftazidime with avibactam, a novel beta lactamase inhibitor that helps tackle

Latest news

Pfizer launches new antibiotic Zavicefta in UK and Germany

The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of complicated Gram-negative bacterial infections requiring hospitalisation last year.
AZ slims down again with sale of antibiotics to Pfizer

The deal includes the approved antibiotics Merrem (meropenem), Zinforo (ceftaroline fosamil) and just-licensed Zavicefta (ceftazidime/avibactam), as well as two injectable antibiotic candidates - Allergan-partnered ATM-AVI (aztreonam/avibactam) and
AZ gets EU green light for new antibiotic Zavicefta

The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of serious Gram-negative bacterial infections requiring hospitalization.
Merck starts pivotal trials of new antibiotic combination

aeruginosa. AstraZeneca (AZ) recently secured CHMP backing in Europe for Zavicefta - which combines established cephalosporin antibiotic ceftazidime with new-generation beta lactamase inhibitor avibactam.
CHMP backs AZ's 'superbug' antibiotic product

The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Zavicefta (ceftazidime/avibactam), which combines an established antibiotic with a new drug designed to overcome bacterial resistance. ... In the US, Actavis (now operating

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Deal Watch August 2016

14, 000. AstraZeneca (UK) antibiotic business. Pfizer (US). Asset acquisition. EU approved ceftazidime-avibactam), marketed meropenem and ceftaroline fosamil and clinical development assets aztreonam-avibactam (ATM-AVI) and CXL.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Medical/ Scientific Director: Salary TBC

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Director: Excellent benefits

Events Manager – Med Comms – Surrey: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Medical Writers: Competitive Salary and Benefits

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Medical Writer: Competitive Salary

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Medical Writer (Remote Working): Competitive Salary Offered

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Senior Account Manager: Negotiable

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Associate Director: £75, 000-90, 000

Medical Writers Required – Cheshire: DOE

Senior Medical Writer: Great salary and benefits

Senior Account Executive, London, Medical Communications: Excellent package

Production Manager – Healthcare Communications: DOE

Director, Market Access / HEOR - North-West: Negotiable

New Business Director - PR: Competitive Salary and benefits

Project / Account Manager (Medical Education): Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health: For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...